TrialCritical care (London, England)2023

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.

Patrick M Wieruszewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.